Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
BI will pay Priaxon as much as $123 million in upfront payments and milestones for developments in mdm2/p53 regulators, and as much as $72 million in payments to Micromet to commercialize a BiTE antibody to treat multiple myeloma
Zhengchao, Editor
N-acetylcysteine as an add-on to directly observed therapy short-I therapy in fresh pulmonary tuberculosis patients: a randomized, placebo-controlled, double-blinded study
What we know Higher coffee intake has been associated with higher blood homocysteine concentration
The complete peptide list shows the full range of options available for various health goals
US$ 23.20
US$ 29.43
US$ 22.20
.jpg?v=1738588738755)
